HIGHLIGHTS
- who: Vipan K. Parihar and Charles L. Limoli from the Department of Radiation Oncology, University of California, Irvine, Irvine, CA, United States have published the research work: The Cannabinoid Receptor 1 Reverse Agonist AM251 Ameliorates Radiation-Induced Cognitive Decrements, in the Journal: (JOURNAL)
- what: This study provides novel evidence that AM251 provides wide-ranging benefits to the irradiated CNS. The authors investigated the protective effects of AM251 on select cognitive, cellular, and molecular endpoints impacted by cranial irradiation.
- how: 2 days after the last injection of AM251 (13 weeks after irradiation) animals in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.